Find out about program updates, news features, and families helped by newborn screening.
False positive or abnormal results may be due to immature endocrine or enzyme function in the newborn, the stress of birth on an infant, or the specimen being collected less than 24 hours after birth.
The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that as of January 2025, all newborns are being screened for Guanidinoacetate methyltransferase (GAMT) deficiency through the newborn screening process. If you have any questions, please contact …
The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that beginning July 1, 2024, all newborns screened will be tested for Mucopolysaccharidosis Type II (MPS II). If you have any questions, please contact the Florida NBS …
The Florida Newborn Hearing Screening/Early Hearing Detection and Intervention Program is pleased to announce that beginning December 9, 2021, the Florida Guidelines for Newborn Hearing Screening have been revised. For more information or questions about hearing screenings or the revised …